Dupilumab effective for refractory asthma complicated by recurring chronic eosinophilic pneumonia
Dupilumab promising treatment for refractory asthma complicated by recurring chronic eosinophilic pneumonia suggests a new study published in the Nagoya Journal of Medical Science. Dupilumab-induced hypereosinophilia is mediated by blockade of the IL-4/IL-13 pathway, which reduces eosinophil migration from peripheral blood. The increase in peripheral blood eosinophils may lead to chronic eosinophilic pneumonia (CEP) and/or […]